EUPRAXIA PHARMACEUTICALS INC COM is a security (CUSIP 29842P105) tracked across SEC portfolio filings. 53 institutional managers reported $123.1M on Form 13F as of 2026-06-30.
Showing 15 of 53 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| Affinity Asset Advisors, LLC | New York, NY | $11.5M | 1,589,005 |
| Vivo Capital, LLC | Palo Alto, CA | $9.8M | 1,350,000 |
| Balyasny Asset Management L.P. | Chicago, IL | $9.8M | 1,350,000 |
| Ikarian Capital, LLC | DALLAS, TX | $8.8M | 1,214,741 |
| GREAT POINT PARTNERS LLC | Greenwich, CT | $8.7M | 1,200,000 |
| SCOTIA CAPITAL INC. | TORONTO, A6 | $7.2M | 1,342,178 |
| Point72 Asset Management, L.P. | Stamford, CT | $7.0M | 967,575 |
| UBS Group AG | Zurich, V8 | $5.5M | 762,635 |
| Redmile Group, LLC | San Francisco, CA | $5.1M | 700,000 |
| Rubric Capital Management LP | New York, NY | $5.0M | 691,170 |
| Squadron Capital Management LLC | WESTMONT, IL | $4.9M | 680,000 |
| Ally Bridge Group (NY) LLC | NEW YORK, NY | $4.8M | 660,375 |
| PFM Health Sciences, LP | San Francisco, CA | $3.9M | 540,871 |
| Woodline Partners LP | San Francisco, CA | $3.2M | 440,551 |
| Seven Fleet Capital Management LP | MOUNTAIN VIEW, CA | $3.1M | 433,515 |